ACTA1 and fibrosis: Similar results were also reported by Cong and colleagues, in which Ang II treatment fostered IL-11 expression and α-SMA intensity, while treatment with IL-11 antagonist reduced α-SMA-positive myofibroblasts in atrial tissue from the fibrosis mouse model [11].